RPRX – royalty pharma plc - class a ordinary shares (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

RPRX

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/3

07:33 pm

rprx

Royalty Pharma plc (RPRX) Earns $51 Target as 2026 Growth Outlook Exceeds Expectations [Yahoo! Finance]

Low Report

Royalty Pharma plc (RPRX) Earns $51 Target as 2026 Growth Outlook Exceeds Expectations [Yahoo! Finance]

Report

3/3

03:57 pm

rprx

Royalty Pharma plc (RPRX) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]

Neutral Report

Royalty Pharma plc (RPRX) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]

Report

3/3

05:32 am

rprx

Royalty Pharma (RPRX) Achieves Record Growth and Hits Investment Targets Ahead of Schedule [Yahoo! Finance]

Low Report

Royalty Pharma (RPRX) Achieves Record Growth and Hits Investment Targets Ahead of Schedule [Yahoo! Finance]

Report

3/2

09:15 pm

rprx

Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform

Low Report

Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform

Report

3/2

07:35 am

rprx

Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform [Yahoo! Finance]

Medium Report

Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform [Yahoo! Finance]

Report

3/2

07:00 am

rprx

Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform

Medium Report

Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform

Report

3/2

06:43 am

rprx

Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing [Yahoo! Finance]

Medium Report

Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing [Yahoo! Finance]

Report

3/2

06:13 am

rprx

Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]

Medium Report

Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]

Report

Date

Time

Symbol

Company Name

Action

%Chg

Date

Time

Action

From

Firm

Impact

%Chg

2/12

10:07 am

Reiterates

Overweight

Morgan Stanley

Low

Report

1.3%

Report

2/12

10:07 am

Reiterates

Overweight

Morgan Stanley

Low

Report

1.3%

Report

1/30

06:01 am

Upgrades

Neutral

Buy

UBS Group AG

Low

Report

0.8%

Report

1/30

04:40 am

Upgrades

NEUTRAL

BUY

UBS

Low

Report

0.8%

Report

1/27

09:39 am

Maintains

Buy

Citigroup

Low

Report

0.0%

Report

1/27

09:39 am

Maintains

Buy

Citigroup

Low

Report

0.0%

Report

1/27

07:19 am

Reiterates

Buy

Citigroup Inc.

Low

Report

0.0%

Report

Date

Time

Symbol

Headline

Impact

3/4

05:12 pm

rprx

Form 4 Royalty Pharma plc For: Mar 02 Filed by: Coyne Terrance P.

Medium Report

Form 4 Royalty Pharma plc For: Mar 02 Filed by: Coyne Terrance P.

Report

3/4

04:52 pm

rprx

Form 144 Royalty Pharma plc Filed by: Lloyd George W.

Low Report

Form 144 Royalty Pharma plc Filed by: Lloyd George W.

Report

3/2

05:26 pm

rprx

Form 144 Royalty Pharma plc Filed by: Coyne Terrance P.

Low Report

Form 144 Royalty Pharma plc Filed by: Coyne Terrance P.

Report

2/25

04:08 pm

rprx

Form 4 Royalty Pharma plc For: Feb 23 Filed by: Coyne Terrance P.

Low Report

Form 4 Royalty Pharma plc For: Feb 23 Filed by: Coyne Terrance P.

Report

2/23

05:07 pm

rprx

Form 144 Royalty Pharma plc Filed by: Coyne Terrance P.

Low Report

Form 144 Royalty Pharma plc Filed by: Coyne Terrance P.

Report

2/20

04:28 pm

rprx

Form SCHEDULE 13D/A Royalty Pharma plc Filed by: Severgnini Achille G.

Low Report

Form SCHEDULE 13D/A Royalty Pharma plc Filed by: Severgnini Achille G.

Report

2/13

04:30 pm

rprx

Form SCHEDULE 13G/A Royalty Pharma plc Filed by: Capital International Investors

Low Report

Form SCHEDULE 13G/A Royalty Pharma plc Filed by: Capital International Investors

Report

2/13

04:04 pm

rprx

Form 4 Royalty Pharma plc For: Feb 11 Filed by: Legorreta Pablo G.

Low Report

Form 4 Royalty Pharma plc For: Feb 11 Filed by: Legorreta Pablo G.

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.